Segment and Geographic Information

9 Months Ended

Sep. 30, 2011

Segment and Geographic Information

14. Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Orthobiologics	$	10,377,222	$	7,675,342	$	28,177,115	$	22,321,859
Dermal		947,122		318,833		2,335,881		2,402,852
Ophthalmic		4,562,574		3,332,883		8,045,203		8,768,851
Surgical		1,068,522		1,187,378		3,748,277		2,974,869
Veterinary		800,560		664,963		1,924,364		2,073,947
	$	17,756,000	$	13,179,399	$	44,230,840	$	38,542,378

                 Product revenue by geographic location in total and as a percentage of total product revenue, for the three and nine months ended September 30, 2011 and 2010 are as follows:

	Three Months Ended September 30,
	2011					2010
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	13,233,998		75	%	$	9,212,832		70	%
Europe		2,841,650		17	%		2,850,595		22	%
Other		1,680,352		8	%		1,115,972		8	%
Total	$	17,756,000		100	%	$	13,179,399		100	%

	Nine Months Ended September 30,
	2011					2010
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	33,172,102		75	%	$	26,488,673		69	%
Europe		7,478,869		18	%		9,024,021		23	%
Other		3,579,869		7	%		3,029,684		8	%
Total	$	44,230,840		100	%	$	25,362,979		100	%